Inhibition of Testosterone Biosynthesis in Testicular Microsomes by Various Imidazole Drugs. Comparative Study with Ketoconazole
スポンサーリンク
概要
- 論文の詳細を見る
Ketoconazole (KCZ), an imidazole-containing antimycotic, has been demonstrated to inhibit testosterone biosynthesis in man. In this study, the inhibitory activities of various imidazole drugs such as miconazole (MCZ), cimetidine (CIM), ozagrel (OZA) and its metabolites (M-1 and M-2) on the pathway of testosterone biosynthesis in testicular microsomes were compared with that of KCZ in vitro. Additionally, the changes in serum testosterone level in the patients by the treatments with MCZ were followed. KCZ inhibited 17α-hydroxylase and C^<17,20>-lyase activities in a dose-depentent manner, while it did not affect 17β-hydroxysteroid dehydrogenase activity. Although the patterns of the inhibitory actions and the interaction of either imidazole drugs with cytochrome P-450 as 17α-hydroxylase and C_<17,20>-lyase were similar to those of KCZ, the inhibitory potencies and affinities for the cytochrome P-450 system decreased in the order of KCZ>MCZ>OZA>M-2>M-1>CIM. At the end of the intravenous injection of 200 mg MCZ to the patients, the serum testosterone levels decreased by about 16% of the original level and then returned to the original level 5h after the end of injection. These results indicate that either imidazole drugs tested colud inhibit a cuytochrome P-450 enzyme C_<17,20>-lyase mainly in testicular microsomes, and suggest that MCZ, a potent inhibitor subsequent to KCZ, induces a slight alteration in the testosterone biosynthesis in its clinical use.
- 公益社団法人日本薬学会の論文
著者
-
Ono Takeshi
Hospital Pharmacy Shiga University Of Medical Science
-
Shimakawa H
Shiga Univ. Medical Science
-
Morita Kunihiko
Hospital Pharmacy Shiga University Of Medical Science
-
SHIMAKAWA Harumi
Hospital Pharmacy, Shiga University of Medical Science
-
Shimakawa Harumi
Hospital Pharmacy Shiga University Of Medical Science
関連論文
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS A POORLY ABBSORBABLE DRUG. III.^ HISTOLOGICAL STUDY AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RATS
- EFFECT OF ADMINISTRATION ROUTE ON THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. II. STUDY ON THE ABSORPTION PROMOTING EFFECT OF AZONE
- PROMOTION OF THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. I. COMPARISON OF PLASMA LEVELS AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RAT
- Inhibition of Testosterone Biosynthesis in Testicular Microsomes by Various Imidazole Drugs. Comparative Study with Ketoconazole
- A Model to Account for the Blood-to-Plasma Distribution of Cyclosporin A in Human Blood
- Effects of Antimycotics on Hepatic Steroid Metabolism
- Effects of Ozagrel (OKY-046), a Thromboxane Synthase Inhibitor, on Oxidative Drug-Metabolizing Enzymes in Mouse Hepatic Microsomes
- Effects of Diltiazem on Rheological Properties of Human Blood
- Inhibitory Effects of Ketoconazole and Miconazole on Cytochrome P-450-Mediated Oxidative Metabolism of Testosterone and Xenobiotics in Mouse Hepatic Microsomes-Comparative Study with Cimetidine
- A COMPARISON OF THE INHIBITORY EFFECTS OF ROXATIDINE ACETATE HYDROCHLORIDE AND CIMETIDINE ON CYTOCHROME P-450-MEDIATED DRUG-METABOLISM IN MOUSE HEPATIC MICROSOMES AND IN MAN IN VIVO
- Selective Inhibition of Hepatic Microsomal Drug-Metabolism by Mexiletine Hydrochloride
- Retrospective Pharmacokinetic Data Analysis of Cyclosporin A Using Routine Monitoring Data in Renal Transplant Patients : Consideration on Its Pharmacokinetic Profiles and Physiological Factors during Renal Dysfunction
- Evaluation of fluorescence polarization immunoassay for determination of cyclosporin in whole blood and its clinical relevance.